Skip to Main Content

Paper Details

A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer.
Clin Cancer Res
10
2020
Author NameAffiliation
Nora M NavoneThe University of Texas MD Anderson Cancer Center
Eleni EfstathiouThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2